Phase 2 Bone Marrow Transplant Clinical Trials
6 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–6 of 6 trials
Recruiting
Phase 2
Low-Dose ATG/PTCy Plus Ivarmacitinib for aGVHD Prevention in Haplo-PBSCT From Parous Female Donors
Graft-Versus-Host-Disease (GVHD)Bone Marrow Transplantation
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine82 enrolled1 locationNCT07570745
Recruiting
Phase 2
MAGIC Ruxolitinib for aGVHD
Acute Graft Versus Host Diseaseadverse effectsAllogeneic Bone Marrow Transplantation
John Levine98 enrolled14 locationsNCT06936566
Recruiting
Phase 2
Orphan Indications for CD19 Redirected Autologous T Cells
Pediatric and Young Adult Patientswith Hypodiploid or t(17;19) B-ALLInfants With Very High Risk KMT2A B-ALLPatients With Central Nervous System Relapse Who Did Not Receive Cranial Radiation or Bone Marrow Transplantation
Stephan Grupp MD PhD133 enrolled1 locationNCT04276870
Recruiting
Phase 2
Shingrix In Recipients of Allogeneic Transplants
Bone Marrow TransplantStem Cell Transplant
University of Colorado, Denver55 enrolled1 locationNCT05775718
Recruiting
Phase 2Phase 3
Post Transplant Cyclophosphamide in Matched Unrelated Donor Stem Cell Transplantation for Hematological Malignancies
Graft-Versus-Host DiseaseBone Marrow Transplant ComplicationsImmunologic Suppression+2 more
Hospital Israelita Albert Einstein50 enrolled1 locationNCT03818334
Withdrawn
Phase 2
Prospective study of Rituximab for chronic graft vs host disease (GVHD) sub-optimally responsive to immunosuppressive therapy: Assessment of response.
Chronic graft versus host disease post allogeneic bone marrow transplant
Australasian Leukaemia and Lymphoma Group20 enrolled1 locationACTRN12606000326594